Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DSM265 in acute uncomplicated P. falciparum or P. vivax malaria
NCT02123290Phase 2Completed
- Sponsor
- Medicines for Malaria Venture
- Start
- Jan 2016
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DSM265 in Plasmodium falciparum malaria, Plasmodium vivax malaria, sponsored by Medicines for Malaria Venture. Started Jan 2016; status: completed.
02
Drugs
DSM265
03
Conditions
Plasmodium falciparum malariaPlasmodium vivax malaria
Beyond the preview
Go deeper on NCT02123290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02123290.